1478 related articles for article (PubMed ID: 27999119)
1. Transgender men's experiences of fertility preservation: a qualitative study.
Armuand G; Dhejne C; Olofsson JI; Rodriguez-Wallberg KA
Hum Reprod; 2017 Feb; 32(2):383-390. PubMed ID: 27999119
[TBL] [Abstract][Full Text] [Related]
2. Fertility preservation and fertility treatment in transgender adolescents and adults in a Swedish region, 2013-2018.
Mattelin E; Strandell A; Bryman I
Hum Reprod Open; 2022; 2022(2):hoac008. PubMed ID: 35309678
[TBL] [Abstract][Full Text] [Related]
3. Factors Affecting Fertility Decision-Making Among Transgender Adolescents and Young Adults.
Chen D; Kyweluk MA; Sajwani A; Gordon EJ; Johnson EK; Finlayson CA; Woodruff TK
LGBT Health; 2019 Apr; 6(3):107-115. PubMed ID: 30985275
[TBL] [Abstract][Full Text] [Related]
4. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives.
Martinez F
Hum Reprod; 2017 Sep; 32(9):1802-1811. PubMed ID: 29117320
[TBL] [Abstract][Full Text] [Related]
5. Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study.
Delattre S; Segers I; Van Moer E; Drakopoulos P; Mateizel I; Enghels L; Tournaye H; De Vos M
Hum Reprod; 2020 Nov; 35(11):2524-2536. PubMed ID: 32951035
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study.
Marklund A; Eloranta S; Wikander I; Kitlinski ML; Lood M; Nedstrand E; Thurin-Kjellberg A; Zhang P; Bergh J; Rodriguez-Wallberg KA
Hum Reprod; 2020 Apr; 35(4):929-938. PubMed ID: 32313940
[TBL] [Abstract][Full Text] [Related]
7. Fertility preservation for transgender adolescents and young adults: a systematic review.
Baram S; Myers SA; Yee S; Librach CL
Hum Reprod Update; 2019 Nov; 25(6):694-716. PubMed ID: 31633751
[TBL] [Abstract][Full Text] [Related]
8. Experiences and intentions of patients undergoing medically indicated oocyte or embryo cryopreservation: a qualitative study.
Bayefsky MJ; Sampson A; Blakemore JK; Jalili D; Lilly AG; Fino ME; Quinn GP
Hum Reprod; 2024 Jan; 39(1):147-153. PubMed ID: 37944107
[TBL] [Abstract][Full Text] [Related]
9. Fertility Preservation for Transgender Adolescents.
Chen D; Simons L; Johnson EK; Lockart BA; Finlayson C
J Adolesc Health; 2017 Jul; 61(1):120-123. PubMed ID: 28363716
[TBL] [Abstract][Full Text] [Related]
10. What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation?
Sonigo C; Simon C; Boubaya M; Benoit A; Sifer C; Sermondade N; Grynberg M
Hum Reprod; 2016 Jul; 31(7):1493-500. PubMed ID: 27165625
[TBL] [Abstract][Full Text] [Related]
11. Modeling of live-birth rates and cost-effectiveness of oocyte cryopreservation for cancer patients prior to high- and low-risk gonadotoxic chemotherapy.
Lyttle Schumacher B; Grover N; Mesen T; Steiner A; Mersereau J
Hum Reprod; 2017 Oct; 32(10):2049-2055. PubMed ID: 28938728
[TBL] [Abstract][Full Text] [Related]
12. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
[TBL] [Abstract][Full Text] [Related]
13. Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients.
Goldman RH; Racowsky C; Farland LV; Munné S; Ribustello L; Fox JH
Hum Reprod; 2017 Apr; 32(4):853-859. PubMed ID: 28166330
[TBL] [Abstract][Full Text] [Related]
14. Decision-making in female fertility preservation is balancing the expected burden of fertility preservation treatment and the wish to conceive.
Baysal Ö; Bastings L; Beerendonk CC; Postma SA; IntHout J; Verhaak CM; Braat DD; Nelen WL
Hum Reprod; 2015 Jul; 30(7):1625-34. PubMed ID: 26034191
[TBL] [Abstract][Full Text] [Related]
15. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives.
Martinez F;
Fertil Steril; 2017 Sep; 108(3):407-415.e11. PubMed ID: 28739117
[TBL] [Abstract][Full Text] [Related]
16. Reproductive experiences of women who cryopreserved oocytes for non-medical reasons.
Hammarberg K; Kirkman M; Pritchard N; Hickey M; Peate M; McBain J; Agresta F; Bayly C; Fisher J
Hum Reprod; 2017 Mar; 32(3):575-581. PubMed ID: 28077428
[TBL] [Abstract][Full Text] [Related]
17. Fertility Preservation in Male to Female Transgender Patients.
Liu W; Schulster ML; Alukal JP; Najari BB
Urol Clin North Am; 2019 Nov; 46(4):487-493. PubMed ID: 31582023
[TBL] [Abstract][Full Text] [Related]
18. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.
Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N
Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139
[TBL] [Abstract][Full Text] [Related]
19. Attitudes and experiences of health care professionals when caring for transgender men undergoing fertility preservation by egg freezing: a qualitative study.
Armuand G; Dhejne C; Olofsson JI; Stefenson M; Rodriguez-Wallberg KA
Ther Adv Reprod Health; 2020; 14():2633494120911036. PubMed ID: 32518917
[TBL] [Abstract][Full Text] [Related]
20. Knowledge, attitudes, and intentions toward fertility awareness and oocyte cryopreservation among obstetrics and gynecology resident physicians.
Yu L; Peterson B; Inhorn MC; Boehm JK; Patrizio P
Hum Reprod; 2016 Feb; 31(2):403-11. PubMed ID: 26677956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
